Paper39635124
IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection.
Diniz-Lima I and 13 others. iScience, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection. Papers, record 39635124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39635124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27351934 | IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema. | Am J Respir Cell Mol Biol | 2016 | https://conductscience.org/library/papers/27351934 | PubMed |
| 2 | 29793796 | Emerging IL-12 family cytokines in the fight against fungal infections. | Cytokine | 2018 | https://conductscience.org/library/papers/29793796 | PubMed |
| 3 | 19635827 | Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. | Infect Immun | 2009 | https://conductscience.org/library/papers/19635827 | PubMed |
| 4 | 16393998 | IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. | J Immunol | 2006 | https://conductscience.org/library/papers/16393998 | PubMed |
| 5 | 34576780 | Titan Cells and Yeast Forms of Cryptococcus neoformans and Cryptococcus gattii Are Recognized by GXMR-CAR. | Microorganisms | 2021 | https://conductscience.org/library/papers/34576780 | PubMed |
| 6 | 30852797 | Cryptococcus gattii VGII isolated from native forest and river in Northern Brazil. | Braz J Microbiol | 2019 | https://conductscience.org/library/papers/30852797 | PubMed |
| 7 | 20585559 | Cryptococcal cell morphology affects host cell interactions and pathogenicity. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/20585559 | PubMed |
| 8 | 35169117 | IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. | Nat Commun | 2022 | https://conductscience.org/library/papers/35169117 | PubMed |
| 9 | 31813737 | The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections. | Wilderness Environ Med | 2020 | https://conductscience.org/library/papers/31813737 | PubMed |
| 10 | 9093628 | The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. | Trans R Soc Trop Med Hyg | 1997 | https://conductscience.org/library/papers/9093628 | PubMed |
| 11 | 36091010 | IL-22 regulates endometrial regeneration by enhancing tight junctions and orchestrating extracellular matrix. | Front Immunol | 2022 | https://conductscience.org/library/papers/36091010 | PubMed |
| 12 | 21291588 | Risk factors for Cryptococcus gattii infection, British Columbia, Canada. | Emerg Infect Dis | 2011 | https://conductscience.org/library/papers/21291588 | PubMed |
| 13 | 38786693 | Inhibition of Microbicidal Activity of Canine Macrophages DH82 Cell Line by Capsular Polysaccharides from Cryptococcus neoformans. | J Fungi (Basel) | 2024 | https://conductscience.org/library/papers/38786693 | PubMed |
| 14 | 22246551 | Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. | Lung | 2012 | https://conductscience.org/library/papers/22246551 | PubMed |
| 15 | 31275938 | Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans. | Front Med (Lausanne) | 2019 | https://conductscience.org/library/papers/31275938 | PubMed |
| 16 | 29184017 | Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species. | mBio | 2017 | https://conductscience.org/library/papers/29184017 | PubMed |
| 17 | 29467743 | Genotypic and Phenotypic Diversity of Cryptococcus gattii VGII Clinical Isolates and Its Impact on Virulence. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29467743 | PubMed |
| 18 | 22544904 | Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. | Eukaryot Cell | 2012 | https://conductscience.org/library/papers/22544904 | PubMed |
| 19 | 21843086 | Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. | Immunotherapy | 2011 | https://conductscience.org/library/papers/21843086 | PubMed |
| 20 | 12010985 | Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. | Infect Immun | 2002 | https://conductscience.org/library/papers/12010985 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41929258 | Interleukin-23 in lung and airway diseases: from pathogenesis to precision-guided therapeutic targeting. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41929258 | PubMed |
| 41258798 | Oral L-Arginine treatment attenuates Cryptococcus neoformans extrapulmonary dissemination and disease progression. | Virulence | 2025 | https://conductscience.org/library/papers/41258798 | PubMed |
| 41156732 | The Capsular Polysaccharides GXM and GXMGal from Cryptococcus neoformans Modulate Macrophages Infected with Leishmania major. | Microorganisms | 2025 | https://conductscience.org/library/papers/41156732 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39635124
GET https://conductscience.org/api/papers/v1/39635124/references?page=2